Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 11, 2025BMC Infectious DiseasesOpen Access

Molecular characterization of blaNDM and other carbapenemases genes among carbapenem-resistant Enterobacterales from community-and hospital- acquired urinary tract infections

View Full Paper
Ask AI
Bookmark
Share

Authors

LRLubna RazaqFUFakhur UddinWAWissal Audah Alhilfi

Discussion

Loading...

Member takes

Overview

Analysis identifies high prevalence of carbapenem-resistant Enterobacterales in hospital-acquired infections, suggesting urgent action is needed.

Key Points

  • In hospital-acquired (HA) urinary tract infections, carbapenem resistance was significantly higher at 60.8%, compared to 6.5% in community-acquired (CA) cases.
  • The blaNDM gene was detected in 86.5% of carbapenem-resistant Enterobacterales (CRE), indicating a significant threat in treatment options.
  • Among 181 isolates, E. coli was the prevalent uropathogen at 70.7%, highlighting the need for targeted intervention strategies.
  • Chi-square analysis demonstrated significantly greater antimicrobial resistance in HA-UTI isolates compared to CA-UTI, stressing the need for awareness.

Cite This Study

Razaq et al. (2025) studied this question.

synapsesocial.com/papers/68ea72339f1bd4df558ced1ahttps://doi.org/10.1186/s12879-025-11548-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phylogenetic analysis of bla NDM genes of carbapenem resistant uropathogens isolated from federal tertiary care hospital, Pakistan: insights into the evolution and dissemination of drug resistance2025
  2. 2A-254 Molecular characterization of carbapenem and colistin resistance in isolates causing UTI at an outpatient setting of a tertiary care hospital2025 · 1 citations
  3. 3Carbapenem resistence and Carbapenemase classification of Enterobacteriaceae in Intensive Care Unit: A cross-sectional study2025
  4. 4Prevalence, molecular carbapenemase detection, and antibiotic resistance of carbapenem-resistant <i>Enterobacterales</i> in a tertiary care hospital in East Jerusalem (2019–2023): a retrospective study2025
  5. 5Detection of carbapenemase production in Enterobacterales by mCIM and eCIM: a tertiary care hospital study2025